A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
Clinical trial NCT04838964 · UNKNOWN
Trial details
- NCT number
- NCT04838964
- Sponsor
- Shanghai Miracogen Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2024-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.